Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

agilon health, inc. Stock Research

AGL

18.17USD-0.40(-2.15%)Market Closed
Watchlist

Market Summary

USD18.17-0.40
Market Closed
-2.15%

AGL Alerts

  • 2 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Losses in recent quarter

AGL Stock Price

AGL RSI Chart

AGL Valuation

Market Cap

7.4B

Price/Earnings (Trailing)

-83.84

Price/Sales (Trailing)

2.01

EV/EBITDA

-111.22

Price/Free Cashflow

-51.14

AGL Price/Sales (Trailing)

AGL Profitability

EBT Margin

-2.89%

Return on Equity

-8.48%

Return on Assets

-4.23%

Free Cashflow Yield

-1.96%

AGL Fundamentals

AGL Revenue

Revenue (TTM)

3.7B

Revenue Y/Y

71.47%

Revenue Q/Q

1.14%

AGL Earnings

Earnings (TTM)

-87.9M

Earnings Y/Y

18.89%

Earnings Q/Q

-204.54%

Price Action

52 Week Range

15.0029.44
(Low)(High)

Last 7 days

2.2%

Last 30 days

2.4%

Last 90 days

6.4%

Trailing 12 Months

-23.5%

AGL Financial Health

Current Ratio

1.93

AGL Investor Care

Buy Backs (1Y)

0.47%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for AGL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-13
Shaker Benjamin
acquired
71,062
3.79
18,750
chief markets officer
2023-09-13
Shaker Benjamin
sold
-337,455
17.9976
-18,750
chief markets officer
2023-09-12
Shaker Benjamin
acquired
71,062
3.79
18,750
chief markets officer
2023-09-12
Shaker Benjamin
sold
-338,481
18.0523
-18,750
chief markets officer
2023-09-11
Gertsch Timothy
sold
-488,616
18.6139
-26,250
chief accounting officer
2023-09-11
Gertsch Timothy
acquired
196,700
7.49333
26,250
chief accounting officer
2023-08-16
Gertsch Timothy
acquired
-
-
5,603
chief accounting officer
2023-08-15
Shaker Benjamin
acquired
71,062
3.79
18,750
chief markets officer
2023-08-15
Shaker Benjamin
sold
-339,309
18.0965
-18,750
chief markets officer
2023-08-14
Shaker Benjamin
sold
-351,082
18.7244
-18,750
chief markets officer

1–10 of 50

Which funds bought or sold AGL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-08-25
Yarbrough Capital, LLC
unchanged
-
-97,451
263,620
0.01%
2023-08-22
COMERICA BANK
new
-
2,000
2,000
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
new
-
279,174
279,174
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
42.99
262,667
6,239,970
0.01%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
new
-
1,774,000
1,774,000
0.02%
2023-08-21
BOKF, NA
sold off
-100
-738,340
-
-%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-42.49
-1,209,470
855,529
-%
2023-08-17
Durable Capital Partners LP
added
9.68
-26,041,700
104,658,000
0.92%
2023-08-16
Nuveen Asset Management, LLC
added
41.19
390,558
13,051,600
-%
2023-08-16
Neo Ivy Capital Management
new
-
5,000
5,000
-%

1–10 of 41

Latest Funds Activity

Are funds buying AGL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AGL
No. of Funds

Schedule 13G FIlings of agilon health

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Sep 08, 2023
morgan stanley
10.7%
43,556,373
SC 13G/A
Sep 08, 2023
wellington management group llp
10.14%
41,124,989
SC 13G/A
Mar 10, 2023
capital world investors
10.3%
42,425,420
SC 13G/A
Feb 13, 2023
capital world investors
9.2%
37,918,473
SC 13G/A
Feb 08, 2023
morgan stanley
9.1%
37,574,546
SC 13G/A
Feb 06, 2023
wellington management group llp
5.52%
22,745,297
SC 13G
Jan 10, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2022
cd&r vector holdings, l.p.
52.3%
205,948,808
SC 13G
Feb 11, 2022
capital world investors
9.1%
35,865,953
SC 13G
Feb 09, 2022
fmr llc
-
0
SC 13G

Recent SEC filings of agilon health

View All Filings
Date Filed Form Type Document
Sep 14, 2023
4
Insider Trading
Sep 13, 2023
4
Insider Trading
Sep 12, 2023
144
Notice of Insider Sale Intent
Sep 08, 2023
SC 13G/A
Major Ownership Report
Sep 08, 2023
SC 13G/A
Major Ownership Report
Aug 18, 2023
3
Insider Trading
Aug 18, 2023
4
Insider Trading
Aug 16, 2023
8-K
Current Report
Aug 16, 2023
4
Insider Trading
Aug 08, 2023
10-K/A
Annual Report

agilon health News

Best Stocks
Assessing the Mixed Performance of agilon health: Confidence in ....
Best Stocks,
4 hours ago
24/7 Wall St.
Seeking Alpha
Clayton County Register
Facebook.
Clayton County Register,
46 days ago

Returns for AGL

Cumulative Returns on AGL

Risks for AGL

What is the probability of a big loss on AGL?

89.8%


Probability that agilon health stock will be more than 20% underwater in next one year

82.8%


Probability that agilon health stock will be more than 30% underwater in next one year.

80.5%


Probability that agilon health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does AGL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if agilon health was unfortunately bought at previous high price.

Drawdowns

Financials for agilon health

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42018Q4
Revenue15.0%3,669,831,0003,190,913,0002,708,211,0002,481,323,0002,245,078,0002,073,900,0001,833,559,0001,691,680,0001,545,751,0001,340,389,0001,218,333,0001,196,434,6671,169,284,0001,164,192,000794,411,000474,827,000
Operating Expenses-100.0%-3,304,340,0002,828,642,0002,580,509,0002,350,347,0002,456,480,0002,227,511,0002,077,502,0001,905,816,0001,403,343,0001,275,006,0001,219,008,0001,183,456,0001,187,528,000900,985,000546,891,000
  S&GA Expenses12.0%275,532,000245,957,000218,945,000197,578,000192,241,000457,878,000455,821,000448,073,000431,798,000148,485,000137,292,000122,961,333123,706,000110,420,000122,832,00088,745,000
EBITDA100.0%--72,369,000-87,392,000-89,852,000-96,313,000-371,657,000-383,908,000-364,309,000-339,323,000-45,515,000-40,677,000-9,986,666-1,042,000-10,056,000-93,366,000-60,068,000
EBITDA Margin100.0%--0.02-0.03-0.04-0.04-0.18-0.21-0.22-0.22-0.03-0.03-0.010.00-0.01-0.12-0.13
Interest Expenses12.4%5,830,0005,187,0004,525,0003,656,0003,523,0004,076,0006,146,0007,259,0008,345,0008,927,0008,135,0008,242,6678,458,0008,596,0009,068,0009,839,000
Earnings Before Taxes5.1%-87,408,000-92,144,000-105,689,000-106,994,000-113,787,000-390,223,000-404,598,000-386,161,000-361,690,000-68,202,000-62,343,000-31,377,333-22,534,000-31,444,000-114,687,000-81,292,000
EBT Margin100.0%--0.03-0.04-0.04-0.05-0.19-0.22-0.23-0.23-0.05-0.05-0.03-0.02-0.03-0.14-0.17
Net Income4.3%-87,861,000-91,761,000-106,553,000-106,808,000-111,983,000-390,179,000-406,487,000-373,981,000-349,965,000-59,031,000-60,052,000-47,782,666-48,020,000-64,396,000-282,588,000-146,926,000
Net Income Margin100.0%--0.03-0.04-0.04-0.05-0.19-0.22-0.22-0.23-0.04-0.05-0.04-0.04-0.06-0.36-0.31
Free Cashflow100.0%--183,480,000-146,234,000-145,083,000-165,958,000-140,999,000-154,723,000-116,283,000-99,305,000-69,513,000-54,979,000-54,829,333-72,878,000-105,888,000-106,753,000-69,632,000
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42019Q4
Assets8.4%2,3532,1701,6971,8701,8411,8551,5861,6851,702574446403
  Current Assets9.0%2,0451,8761,4511,6341,6011,6281,3671,4531,480418294246
    Cash Equivalents-51.6%1913944975516841,0221,0551,0821,109105135139
  Net PPE10.3%24.0022.0020.0018.0016.0013.009.006.005.005.006.007.00
  Goodwill-0.1%62.0062.0042.0042.0042.0042.0042.0042.0042.0042.0042.0042.00
Liabilities35.4%1,4731,088657785737744495558551563422354
  Current Liabilities40.1%1,362973535658605610357423412372267200
    LT Debt, Current0%5.005.005.005.005.005.005.005.004.00-3.003.00
    LT Debt, Non Current-3.3%36.0037.0038.0040.0041.0042.0043.0045.0046.0099.0065.0067.00
Shareholder's Equity-18.6%8801,0821,0411,0861,1031,1111,0921,1271,150---
  Retained Earnings-1.6%-1,064-1,048-1,064-1,007-977-956-957-900-865-566-551-491
  Additional Paid-In Capital-8.6%1,9472,1302,1072,0952,0762,0642,0462,0252,012266264257
Shares Outstanding-2.2%405414412412407402400391377326249295
Minority Interest-6.8%-0.72-0.67-0.61-0.53-0.46-0.37-0.30-0.28-0.17-0.07--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42018Q4
Cashflow From Operations23.2%-129-168-130-129-151-130-148-112-97.82-67.90-53.20-53.15-71.00-104-103-67.53
  Share Based Compensation34.2%51.0038.0028.0023.0027.002952922902797.007.006.006.004.005.004.00
Cashflow From Investing65.1%-169-486-444-439-319-90.30-90.51-64.63-51.9213.0022.00-1.61-4.701.00-5.06-7.97
Cashflow From Financing-901.5%-18323.0028.0037.0029.001,1381,1541,1431,13628.0025.0034.0063.0010917685.00
  Buy Backs-806---------7.0027.00---2.00

AGL Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:    
Revenues$ 1,149,052$ 670,134$ 2,285,199$ 1,323,579
Expenses:    
General and administrative (including noncash stock-based compensation expense of $19,572, $6,553, $33,244 and $10,523, respectively)81,49951,924148,34591,758
Depreciation and amortization5,5153,0429,7046,415
Total expenses1,178,873691,1862,308,7591,345,374
Income (loss) from operations(29,821)(21,052)(23,560)(21,795)
Other income (expense):    
Other income (expense), net15,6876,99725,1599,266
Gain (loss) on lease terminations0(5,458)0(5,458)
Interest expense(1,588)(945)(3,121)(1,816)
Income (loss) before income taxes(15,722)(20,458)(1,522)(19,803)
Income tax benefit (expense)(1,073)(580)686(509)
Income (loss) from continuing operations(16,795)(21,038)(836)(20,312)
Discontinued operations:    
Income (loss) before income taxes03210750
Income tax benefit (expense)0(14)0(14)
Total discontinued operations03070736
Net income (loss)(16,795)(20,731)(836)(19,576)
Noncontrolling interests’ share in (earnings) loss4682109157
Net income (loss) attributable to common shares$ (16,749)$ (20,649)$ (727)$ (19,419)
Net income (loss) per common share, basic and diluted    
Continuing operations, basic (in dollars per share)$ (0.04)$ (0.05)$ 0$ (0.05)
Continuing operations, diluted (in dollars per share)(0.04)(0.05)0(0.05)
Discontinued operations, basic (in dollars per share)0000
Discontinued operations, diluted (in dollars per share)$ 0$ 0$ 0$ 0
Weighted average shares outstanding    
Basic (in shares)410,338407,339411,748404,666
Diluted (in shares)410,338407,339411,748404,666
Medical services revenue    
Revenues:    
Revenues$ 1,147,044$ 669,184$ 2,281,874$ 1,321,607
Expenses:    
Expenses1,008,734587,1401,981,5611,153,348
Other operating revenue    
Revenues:    
Revenues2,0089503,3251,972
Expenses:    
Expenses$ 83,125$ 49,080$ 169,149$ 93,853

AGL Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 190,981$ 497,070
Restricted cash and equivalents10,20410,610
Marketable securities389,046411,901
Receivables, net1,417,052497,574
Prepaid expenses and other current assets, net37,56034,119
Total current assets2,044,8431,451,274
Property and equipment, net24,40720,050
Intangible assets, net94,18567,680
Goodwill62,14041,540
Other assets, net127,346116,924
Total assets2,352,9211,697,468
Current liabilities:  
Medical claims and related payables1,099,533346,727
Accounts payable and accrued expenses257,819183,364
Current portion of long-term debt5,0005,000
Total current liabilities1,362,352535,091
Long-term debt, net of current portion36,01738,482
Other liabilities75,10683,286
Total liabilities1,473,475656,859
Commitments and contingencies
Stockholders' equity (deficit):  
Common stock, $0.01 par value: 2,000,000 shares authorized; 405,427 and 412,385 shares issued and outstanding, respectively4,0544,124
Additional paid-in capital1,947,4382,106,886
Accumulated deficit(1,064,957)(1,064,230)
Accumulated other comprehensive income (loss)(6,369)(5,560)
Total agilon health, inc. stockholders' equity (deficit)880,1661,041,220
Noncontrolling interests(720)(611)
Total stockholders’ equity (deficit)879,4461,040,609
Total liabilities and stockholders’ equity (deficit)$ 2,352,921$ 1,697,468
Steven J. Sell
650
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.